Cargando…

TLR2 – an innate immune checkpoint in multiple sclerosis

Detalles Bibliográficos
Autores principales:	Hossain, Md Jakir, Tanasescu, Radu, Gran, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742083/ https://www.ncbi.nlm.nih.gov/pubmed/26459385

Ejemplares similares

The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker
por: Hossain, Md Jakir, et al.
Publicado: (2018)

Editorial: Preventing multiple sclerosis
por: Dobson, Ruth, et al.
Publicado: (2022)

Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
por: Morandi, Elena, et al.
Publicado: (2019)

The Potential for EBV Vaccines to Prevent Multiple Sclerosis
por: Maple, Peter A., et al.
Publicado: (2022)

An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination
por: Maple, Peter A. C., et al.
Publicado: (2020)

Increased IL-2 and Reduced TGF-β Upon T-Cell Stimulation are Associated with GM-CSF Upregulation in Multiple Immune Cell Types in Multiple Sclerosis
por: Aram, Jehan, et al.
Publicado: (2020)

The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis
por: Morandi, Elena, et al.
Publicado: (2017)

Innate immunity in systemic sclerosis
por: O’Reilly, S.
Publicado: (2020)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu, Radu, et al.
Publicado: (2013)

Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
por: Aram, Jehan, et al.
Publicado: (2018)

Eicosanoids in the Innate Immune Response: TLR and Non-TLR Routes
por: Alvarez, Yolanda, et al.
Publicado: (2010)

Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
por: Hernández-Pedro, Norma Y., et al.
Publicado: (2013)

Enhanced TLR2 responses in multiple sclerosis
por: Fujiwara, M., et al.
Publicado: (2018)

Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis
por: Vilisaar, Janek, et al.
Publicado: (2015)

Immune checkpoints on innate lymphoid cells
por: Chiossone, Laura, et al.
Publicado: (2017)

Thrombotic Processes in Multiple Sclerosis as Manifestation of Innate Immune Activation
por: Koudriavtseva, Tatiana
Publicado: (2014)

Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology
por: Barry, Alison, et al.
Publicado: (2016)

Innate Immune Response to Streptococcus pyogenes Depends on the Combined Activation of TLR13 and TLR2
por: Fieber, Christina, et al.
Publicado: (2015)

TNF-R1, an immune checkpoint in melanoma?
por: Bertrand, Florie, et al.
Publicado: (2015)

Immune checkpoint inhibitors in penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2021)

Innate Immunity of the Lung
por: Greene, Catherine M., et al.
Publicado: (2020)

The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease
por: Spirig, Rolf, et al.
Publicado: (2012)

TLR Cross-talk Confers Specificity to Innate Immunity
por: Tan, Rebecca S. T., et al.
Publicado: (2014)

EFTUD2 on innate immunity
por: Zhu, Chuanlong, et al.
Publicado: (2015)

The dynamics of the immune system and gut in the pathophysiology of multiple sclerosis
por: eBioMedicine
Publicado: (2022)

Dead cell phagocytosis and innate immune checkpoint
por: Yoon, Kyoung Wan
Publicado: (2017)

Structure and functions of Mer, an innate immune checkpoint
por: Ubil, Eric, et al.
Publicado: (2023)

Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis
por: Gross, Catharina C., et al.
Publicado: (2016)

Interaction of TLR4 and TLR8 in the Innate Immune Response against Mycobacterium Tuberculosis
por: Thada, Shruthi, et al.
Publicado: (2021)

Predictors of long-term disability in multiple sclerosis patients using routine magnetic resonance imaging data: A 15-year retrospective study
por: Altokhis, Amjad, et al.
Publicado: (2023)

Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
por: Daei Sorkhabi, Amin, et al.
Publicado: (2023)

Common and specific downstream signaling targets controlled by Tlr2 and Tlr5 innate immune signaling in zebrafish
por: Yang, Shuxin, et al.
Publicado: (2015)

An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
por: Dumitrescu, Laura, et al.
Publicado: (2023)

Innate-Adaptive Immune Crosstalk
por: Shanker, Anil, et al.
Publicado: (2015)

Localised Grey Matter Atrophy in Multiple Sclerosis and Clinically Isolated Syndrome—A Coordinate-Based Meta-Analysis, Meta-Analysis of Networks, and Meta-Regression of Voxel-Based Morphometry Studies
por: Singh, Sonika, et al.
Publicado: (2020)

The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis
por: Echavarria, Raquel, et al.
Publicado: (2023)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Is CD47 an innate immune checkpoint for tumor evasion?
por: Liu, Xiaojuan, et al.
Publicado: (2017)

Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes
por: Pesce, Silvia, et al.
Publicado: (2020)

Triggering Innate Immune Receptors as New Therapies in Alzheimer’s Disease and Multiple Sclerosis
por: Piec, Pierre-Alexandre, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n7tg3apn9tvl6m8ngua6thleu8